{"nct_id":"NCT06890338","title":"A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.","status":"NOT_YET_RECRUITING","status_verified_date":"2025-08","start_date":"2025-08-20","start_date_type":"ESTIMATED","primary_completion_date":"2029-10","primary_completion_date_type":"ESTIMATED","completion_date":"2029-10","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}